Dimitrios C. Mastellos

National Centre of Scientific Research "Demokritos"

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “C3-targeted therapy in periodontal disease: moving closer to the clinic”.

C3-targeted therapy in periodontal disease: moving closer to the clinic

Trends in Immunology(2021)10.1016/j.it.2021.08.001

N/A

1.2DataRank · unranked

46 citations

Hatice Hastürk, John D. Lambris, Danae A. Apatzidou, Georgios N. Belibasakis, Nagihan Bostancı +28 more

Complement C3 vs C5 inhibition in severe COVID-19: Early clinical findings reveal differential biological efficacy

Clinical Immunology(2020)10.1016/j.clim.2020.108598

N/A

0.838DataRank · unranked

265 citations

Bruno G. P. Pires da Silva, Benedito Antônio Lopes da Fonseca, Natasha Peixoto Fonseca, Maria Auxiliadora‐Martins, Sara Mastaglio +18 more

Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions

Progress in Retinal and Eye Research(2020)10.1016/j.preteyeres.2020.100936

N/A

0.673DataRank · unranked

88 citations

Dimitrios C. Mastellos, Yafeng Li, Joshua L. Dunaief, John D. Lambris, Benjamin J. Kim

Prolonged intraocular residence and retinal tissue distribution of a fourth-generation compstatin-based C3 inhibitor in non-human primates

Clinical Immunology(2020)10.1016/j.clim.2020.108391

N/A

0.470DataRank · unranked

22 citations

Justin T. Gumas, Rebecca Lee, Merita Rumano, Nadja Berger, Avneesh Gautam +13 more

Author Correction: ‘Stealth’ corporate innovation: an emerging threat for therapeutic drug development

Nature Immunology(2019)10.1038/s41590-019-0531-x

N/A

0.104DataRank · unranked

1 citations

Anna M. Blom, E. Sander Connolly, Mohamed R. Daha, Brian V. Geisbrecht, Berhane Ghebrehiwet +20 more

The first case of COVID-19 treated with the complement C3 inhibitor AMY-101

Clinical Immunology(2020)10.1016/j.clim.2020.108450

N/A

0DataRank · unranked

297 citations

Annalisa Ruggeri, Antonio M. Risitano, Piera Angelillo, Despina Yancopoulou, Dimitrios C. Mastellos +7 more

Compstatins: the dawn of clinical C3-targeted complement inhibition

Trends in Pharmacological Sciences(2022)10.1016/j.tips.2022.01.004

N/A

0DataRank · unranked

71 citations

Dimitrios C. Mastellos, Daniel Ricklin, John D. Lambris, Christina Lamers